Anteris Technologies Ltd

ASX (AUD): Anteris Technologies Ltd (AVR)

Last Price

9.30

Today's Change

-0.38 (3.92%)

Day's Change

9.30 - 9.76

Trading Volume

5,203

Profile
AVR

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Wayne Geoffrey Paterson Mr. Wayne Geoffrey Paterson

Full Time Employees:  1 1

IPO Date:  2004-03-22 2004-03-22

CIK: 

ISIN:  AU0000088841 AU0000088841

CUSIP:  Q0425C102 Q0425C102

Beta:  0.75 0.75

Last Dividend:  0.00 0.00

Dcf Diff:  9.08 9.08

Dcf:  0.22 0.22

Description

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Address

Toowong Tower,
Toowong, QLD 4066, AU

61 13 0055 0310

http://www.anteristech.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment